In a murine BOS model, Fpr1 knockout mice showed attenuation of disease severity with decreased NF-κB nuclear translocation, MAPK signaling, and modulation of the NLRP3 inflammasome. This evidence concerns the gene FPR1 and Buschke-Ollendorff syndrome.